8 research outputs found

    Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms

    No full text

    Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.

    No full text
    High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015

    Emerging therapeutic agents for advanced non-small cell lung cancer

    No full text

    Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    No full text
    corecore